Impax Investors' Drug Price-Fixing Suit Revived By 9th Circ.
The Ninth Circuit partially revived a shareholder suit Monday alleging generic-drug maker Impax Laboratories Inc. participated in a price-fixing scheme that led to a dip in the company's stock price, finding...To view the full article, register now.
Already a subscriber? Click here to view full article